overshadow disappoint
ew cautiou long-term view around
food industri trend despit improv top-line momentum
see limit lt top-line growth mute
category/geograph growth continu margin struggl
need reinvest
ep overshadow disappoint guidanc stock
 ep beat driven profit line
item overshadow disappoint initi guidanc came
well consensu oper profit guid yoy vs
consensu base busi growth posit side
top-lin trend solid organ sale growth importantli driven
volum growth follow consecut quarter yoy volum declin
multitud product innov throughout solid
intern growth particularli amea contribut top-line
beat vs consensu mind though outweigh two key neg
consider top-line growth pois deceler go forward mse
organ sale growth line manag guidanc
reflect deceler vs counter bull argument
sustain price dissip comparison becom difficult
innov pipelin moder flurri particularli success product
launch cost growth appear high especi
context histor depress advertis spend declin
cumul dollar term past year second point
highlight disappoint initi guidanc embed
high degre advertising/brand-build particularli us cereal segment
manag reiter focu math
guidanc impli roughli bp higher sg spend sale
consid competit natur categori weight averag
market share us scanner data yoy declin consecut
quarter gaining/hold share categori gener
food unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
mute categori growth weight averag categori growth us scanner
sale still-depress spend sale spend
bp cumul past year see risk
continu reinvest forese futur order sustain long-
term growth algorithm organ sale mind remain
cautiou name lower pt lower ep
estim remain ew rel balanc risk-reward roughli
ew result lower ep estim reflect
higher brand-build invest particularli consequ
lower pt continu valu
ebitda multipl roughli line remain
cautiou around long-term growth potenti reinvest need
number adj ep ahead on-
consensu estim driven profit line item still qualiti
solid organ sale growth consensu bp gm
beat drive gross profit upsid vs consensu off-set sg bp higher
sale drove in-lin oper profit organ sale
importantli driven solid volum growth amea volum
growth follow consecut quarter corpor volum declin
price/mix support easi comparison organ sale
averag growth slightli north
america organ sale growth yoy close expect
particularli amea organ yoy profit line incom
lower expect interest expens drove cent ep upsid
quarter
consensu mse price/mix volum net sale
growth support sustain consumpt growth momentum key
brand cheez-it pringl rice krispi frozen food net sale driven
plant-bas meat altern morningstar farm cereal net sale
consumpt declin moder growth share gain acceler
taste-fun segment europ organ sale growth vs consensu
mse led snack particularli pringl latin america organ
sale growth weak vs consensu mse
soften macroeconom condit argentina puerto rico brazil well
distributor transit central america off-set continu
consumpt mexico amea vs consensu mse
growth led africa expans pringl noodl
guidanc includ organ sale growth guidanc yoy vs mse
exclud top-line impact keebler divestitur
impact week adjust oper profit declin yoy
constant currenc basi vs consensu driven divestitur
keebler busi yoy impact pure mechan remov
stand-alon ebit busi exclud potenti benefit
recoveri strand cost partial off-set growth base busi
impli yoy base busi oper profit growth includ benefit
week expect reinvest brand build
adjust ep declin yoy constant currenc basi
base yoy impact divestitur net interest save result
ep rang fx impact neglig base estim
midpoint prior consensu free cash flow
rang vs consensu addit kellogg
comment priorit debt reduct share buyback
tax rate higher lap one-tim discret tax benefit
price target base ev/ebitda support
dcf analysi topline/ebit growth wacc
higher top-line growth greater margin expans re-rat bp
volum upsid better market share trend price upsid bp cost
save upsid multipl expand ebitda
long term organ top-line growth organ sale growth moder
vs acceler slightli long
term line manag lt algorithm oper margin contract
bp reinvestment/brand-build expand bp per year
go forward valuat ev/ebitda impli price-to-earnings
lower price weaker categori volum higher commod pressur price
deterior bp privat label pl pressur categori volum
growth slow health well pressur commod inflat
higher valuat contract ev/ebitda impli price-to-earnings
exhibit bear bull price commod cut driver
bp
arket
believ organ top-line growth
deceler return
vs flat
prior two year higher reinvest
busi contribut
intern growth includ multipro
acquisit bp top-line growth
lt org sale forecast middl
guidanc
includ futur
believ need continu
reinvest behind busi histor
cutback meet top-line growth goal
slight bp lt margin
valuat price-to-earnings pension
adjust basi report
ev/ebitda look fair alreadi price
margin headwind
risk achiev price
expect us snack growth reinvest
dsd save stabil us
cereal busi innov higher ad
spend higher margin expans greater
cost save moder commod
pressur consum shift healthier food
option price pressur us
 sale retail friction lower
oper profit growth higher
reinvest need higher cost pressur
sale
sell administr expens
sg sale
sale bp chang
earn incom tax
earn loss joint ventur
net incom loss attribut non-control interest
incom continu oper
loss /incom attribut non-controlling interest
prepaid
bridg gaap net incom
adjust reconcil net earn oper cash flow
depr amort
dec inc a/r
dec inc inv
inc dec a/p
net chang wc adjust
net cash provid oper activ
net cash use invest activ
flow provid use financ activ
net inc dec note payabl current
issuanc note payabl lt
reduct note payabl lt
issuanc long-term debt
reduct long-term debt
net cash use financ activ
effect exchang rate
chang cash cash equival
cash equival begin period
cash equival end period
